Zybiraa 500 Mg Tablets

Product Description

Zybiraa-500Mg Tablet is an anti-androgen medicine used in the treatment of prostate cancer. It is used to treat metastatic castration-resistant prostate cancer (a condition where cancer does not get controlled with hormonal therapy) and metastatic castration-sensitive prostate cancer (a condition where cancer has spread to other parts of the body but can be controlled) in men. Prostate cancer is a condition that occurs when the prostate gland cells increase abnormally. Symptoms may include difficulty in urinating, pain, numbness, etc.

Zybiraa-500Mg Tablet contains Abiraterone acetate, which belongs to the class of androgen biosynthesis inhibitors. Testosterone is a natural hormone produced by the body. This causes an increase in cancer cells in the prostate gland. Zybiraa-500Mg Tablet works by inhibiting the production of the testosterone hormone and thus stops the growth and spread of cancer. 

Targeted Therapy for Prostate Cancer

Zybiraa 500 mg is formulated specifically for men diagnosed with metastatic castration-resistant prostate cancer. Its active ingredient, Abiraterone Acetate, inhibits androgen production, slowing the progression of cancer. It is only available by prescription, ensuring monitored and appropriate usage by qualified healthcare professionals.


Safe and Effective Administration

Intended for oral administration, Zybiraa tablets provide an easy and convenient route for daily cancer therapy. Each dose should be taken exactly as prescribed, preferably at the same time every day, to maintain consistent drug levels and maximize therapeutic benefits.


Strict Storage and Handling Guidelines

To preserve efficacy and safety, Zybiraa tablets should be stored below 30C, protected from moisture and direct light. Proper storage is essential to maintain the medicine's effectiveness throughout its 24-month shelf life.